TY  - GEN
AU  - Avorn,Jerry
TI  - Evaluating drug effects in the post-Vioxx world: there must be a better way
SN  - 1524-4539
PY  - 2006///0607
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - adverse effects
KW  - Clinical Trials as Topic
KW  - standards
KW  - Cyclooxygenase 2 Inhibitors
KW  - Drug Approval
KW  - legislation & jurisprudence
KW  - Drug Costs
KW  - Drug and Narcotic Control
KW  - Duty to Warn
KW  - Humans
KW  - Information Dissemination
KW  - Lactones
KW  - Myocardial Infarction
KW  - chemically induced
KW  - Probability
KW  - Product Surveillance, Postmarketing
KW  - Research Design
KW  - Risk Assessment
KW  - Stroke
KW  - Sulfones
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Comment; Editorial
UR  - https://doi.org/10.1161/CIRCULATIONAHA.106.625749
ER  -